6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow Trevi Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants NAL ER - Healthy Participants | Phase 1 | Completed | Trevi Therapeutics | 60 | 2026-02-27 | 2026-08-21 |
| NAL ER IPF Respiratory Function and Safety Study NAL ER, Placebo - Idiopathic Pulmonary Fibrosis | Phase 1 | Completed | Trevi Therapeutics | 9 | 2025-08-21 | 2026-08-03 |
| A Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (NAL ER) in Healthy Participants NAL ER, Pirfenidone, Nintedanib - Healthy Participants | Phase 1 | Completed | Trevi Therapeutics | 132 | 2025-06-30 | 2025-10-10 |
| Study of Nalbuphine ER in Participants With Hepatic Impairment Nalbuphine ER - Hepatic Impairment | Phase 1 | Completed | Trevi Therapeutics | 28 | 2019-06-12 | 2026-03-19 |
| Oral Abuse Potential Study of Nalbuphine Nalbuphine HCl solution, Placebo solution - Nalbuphine, Opioid Abuse | Phase 1 | Completed | Trevi Therapeutics | 56 | 2018-05-29 | 2025-05-21 |
| Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus Nalbuphine HCL ER - Uremic Pruritus | Phase 1 | Completed | Trevi Therapeutics | 22 | 2013-04-01 | 2025-05-22 |
Idiopathic Pulmonary Fibrosis (1) · Opioid-Related Disorders (1)
Nalbuphine (3) · nintedanib (1) · pirfenidone (1)
United States (4) · Canada (1) · United Kingdom (1)